Urinary tract infections
Description
- Infection anywhere along the urinary tract - cystitis (lower tract) vs pyelonephritis (upper tract, renal parenchyma involved)
- Uncomplicated (normal anatomy/function, non-pregnant, immunocompetent) vs complicated (structural/functional abnormality, catheter, pregnancy, male, immunosuppressed, obstruction) - drives duration and choice of therapy
Epidemiology
- Among the commonest bacterial infections; F>>M in younger adults (anatomy), gap narrows in older age (prostatic disease)
- ~50-60% of women experience at least one UTI in their lifetime
- Recurrent UTI - >=2 in 6 months or >=3 in 12 months
Aetiopathogenesis
- E. coli - ~75-85% of uncomplicated UTIs; other Enterobacteriaceae (Klebsiella, Proteus), Staphylococcus saprophyticus (young sexually active women)
- Complicated/catheter-associated: broader range - Pseudomonas, Enterococcus, Candida, resistant Gram-negatives
- Risk factors: sexual activity, spermicide use, post-menopausal oestrogen deficiency, incomplete bladder emptying, catheterisation, diabetes, obstruction (stones, BPH), pregnancy (physiological ureteric dilatation)
Diagnosis
Clinical - symptoms required for diagnosis (see Asymptomatic bacteriuria caveat below)
- Cystitis: dysuria, frequency, urgency, suprapubic pain, +/- haematuria
- Pyelonephritis: fever, rigors, flank/loin pain, costovertebral angle tenderness, +/- systemic sepsis features, may or may not have preceding lower tract symptoms
Investigations
- Uncomplicated cystitis in a young woman with classic symptoms: clinical diagnosis, empirical treatment without culture is acceptable per most guidelines
- Midstream urine culture - for pyelonephritis, complicated UTI, recurrent UTI, treatment failure, pregnancy, or male patients
- Blood cultures if systemically unwell/pyelonephritis with sepsis features
- Imaging (renal tract ultrasound, CT) if obstruction suspected, failure to respond to therapy, recurrent pyelonephritis, or renal/perinephric abscess suspected
Asymptomatic bacteriuria - not UTI, do not treat
- Common, especially in older adults, catheterised patients, and pregnancy screening cohorts
- Treat only in pregnancy or before an invasive urological procedure - treating it elsewhere causes harm (resistance, C. difficile) without benefit
Management
A. Uncomplicated cystitis
- Trimethoprim or nitrofurantoin (avoid nitrofurantoin at eGFR <30-45) first-line per Australian eTG; cefalexin alternative
- Duration 3-5 days depending on agent and patient factors
- Avoid fluoroquinolones as first-line given resistance and toxicity profile (tendinopathy, QT, CNS effects)
B. Pyelonephritis
- Uncomplicated, well enough for oral therapy: trimethoprim/sulfamethoxazole or a fluoroquinolone (if susceptibility known/likely) for 7-10 days; cefalexin where trimethoprim/quinolone unsuitable
- Systemically unwell/complicated: IV therapy - typically gentamicin + amoxicillin, or a broad-spectrum cephalosporin, guided by local antibiogram and risk factors for resistant organisms; step down to oral once improving and sensitivities known
- Manage as sepsis if shocked (see Septicaemia and septic shock note)
C. Complicated UTI
- Broader empirical cover accounting for resistant organism risk (recent antibiotics, hospitalisation, catheter, overseas travel)
- Source control - relieve obstruction (stent/nephrostomy), remove/change infected catheter
- Longer duration (typically 7-14 days) depending on severity and response
D. Recurrent UTI prevention
- Vaginal (topical) oestrogen in post-menopausal women - reduces recurrence
- Behavioural measures - hydration, post-coital voiding; cranberry products - weak evidence
- Prophylactic low-dose antibiotics (continuous or post-coital) as a later-line option after non-pharmacological measures fail
- Investigate for structural/functional abnormality if recurrent pyelonephritis or male patient with recurrent UTI
E. Male UTI
- Always regarded as complicated - investigate for prostatic involvement/obstruction; if prostatitis suspected, longer duration (2-4 weeks) with an agent achieving good prostatic penetration (trimethoprim/sulfamethoxazole, fluoroquinolone)
Associations
- Diabetes, urinary tract obstruction/stones, BPH
- Indwelling catheter, recent instrumentation
- Pregnancy
- Vesicoureteric reflux (recurrent childhood UTI/pyelonephritis)
- Immunosuppression
Natural history & complications
- Uncomplicated cystitis - resolves promptly with appropriate short-course therapy
- Pyelonephritis - risk of progression to urosepsis, renal/perinephric abscess, and (rarely) emphysematous pyelonephritis in diabetics if inadequately treated
- Recurrent pyelonephritis can cause chronic scarring and, rarely, chronic kidney disease
- Untreated obstruction with infection (obstructive pyelonephritis) is a urological emergency requiring urgent decompression
🔒
6 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access